What’s Driving Growth in the Animal Gastroesophageal Reflux Disease Market? Insights into Key Trends and Opportunities
Get 15% OFF on all 2025 Global Market Reports until March 31st! Apply code FY25SAVE and grab your savings today!
How has the animal gastroesophageal reflux disease market grown in recent years?
In recent times, the animal gastroesophageal reflux disease market has seen robust growth. A surge from $1.82 billion in 2024 to $1.98 billion in 2025 is anticipated, marking a compound annual growth rate (CAGR) of 8.9%. Factors contributing to this growth in the past include rising pet obesity statistics, advancements in veterinary diagnostic methodologies, increasing consciousness regarding gastrointestinal issues in pets, enhanced veterinary care and treatment choices, a rise in pet ownership and spending on pet health, as well as the emergence of specialty veterinary drugs and diets.
How is the animal gastroesophageal reflux disease market size expected to evolve during the forecast period?
The market for gastroesophageal reflux disease in animals is projected to experience notable expansion in the coming years, surging to a value of $2.76 billion by 2029, with a compound annual growth rate (CAGR) of 8.6%. The anticipated growth during the forecast timeline can be credited to factors such as increasing prevalence of gastrointestinal disorders in pets, amplified demand for superior diagnostic and treatment approaches, heightened awareness and knowledge regarding pet well-being, broader pet insurance coverage and veterinary services, progress in veterinary pharmaceuticals and treatments, rising disposable incomes, and readiness to invest in pet health. Key trends for the forecast period consist of differentiated and personalized treatment options, adoption of cutting-edge diagnostic instruments and technologies, veterinary procedures and services, preventive care and dietary management, and collaborations between veterinary experts and pet owners.
Get your animal gastroesophageal reflux disease market report here!
Which key drivers are propelling the animal gastroesophageal reflux disease market’s growth?
The rise in pet humanization is anticipated to fuel the expansion of the animal gastroesophageal reflux disease segment. Pet humanization refers to the emerging practice of pet owners treating their pets akin to human family members, assigning them human-like feelings, requirements, and actions. The increasing emotional bond between pet owners and their pets drives this trend, which elevates the demand for niche health services, premium food items, and wellness products that match human norms. Pet humanization strengthens the understanding of health problems such as gastroesophageal reflux disease (GERD), encouraging more attentive owners to pursue veterinary treatment and increasing the demand for diagnostics, treatments, and preventive measures. For example, in April 2024, the American Pet Products Association, a US-based non-profit industry body, stated that there were 86.9 million households in the US with a pet in 2023-2024, representing 66% of households, a rise from 62% in 2022. Thus, the growth of pet humanization is leading to the advancement of the animal gastroesophageal reflux disease industry.
What are the market segments in the animal gastroesophageal reflux disease industry?
The animal gastroesophageal reflux disease market covered in this report is segmented –
1) By Product: Treatment, Diagnostics
2) By Mode: Over-The-Counter (OTC), Prescription
3) By Route Of Administration: Oral, Injectable
4) By Animal: Companion Animals, Livestock Animal
5) By Distribution Channel: Veterinary Hospitals And Clinics, Retail Pharmacies, E-Commerce
Subsegments:
1) By Treatment: Medications, Surgical Interventions, Dietary Modifications, Nutritional Supplements, Antacids
2) By Diagnostics: Endoscopy, Esophageal pH Monitoring, Manometry, Ultrasound, Radiographic Studies, Biopsy Techniques
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20464&type=smp
Which leading companies are shaping the growth of the animal gastroesophageal reflux disease market?
Major companies operating in the animal gastroesophageal reflux disease market are Zoetis Inc., VCA Animal Hospitals, Petco Health and Wellness Company Inc., Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Hill’s Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Santé Animale, Virbac S.A., Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Blue Buffalo Company Ltd., Vetoquinol S.A., Antech Diagnostics, Heska Corporation, WellPet LLC, McNeil Consumer Pharmaceuticals Co., Wag Labs Inc., VetPartners Limited, BioZyme Inc., Zomedica Corp., NexGen Pharmaceuticals LLC
What key trends are currently impacting the animal gastroesophageal reflux disease market’s development?
Leading companies in the animal gastroesophageal reflux disease market are creating unique gastrointestinal supportive diets to enhance digestive wellness and regulate symptoms of gastroesophageal reflux disease in pets. These specially designed pet foods help manage and ease symptoms related to gastrointestinal disorders. Such diets usually contain ingredients that are easy to digest, balanced nutrients, and extra fiber or probiotics to improve digestive wellness and overall health. For example, in April 2024, Royal Canin USA, a Mars Incorporated branch that manufactures cat and dog food, increased its veterinary gastrointestinal (GI) offerings by launching five new diets aimed at boosting pets’ gastrointestinal wellness. These special diets, created in partnership with researchers, veterinarians, and experts, are designed to tackle GI problems in dogs and cats, including food-induced sensitivities and fat-limited diets. The new products feature options like gastrointestinal low-fat, hydrolyzed protein canine and gastrointestinal hydrolyzed protein feline, all made with highly digestible ingredients to support ongoing gastrointestinal health.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20464
Which geographic areas are influencing the growth of the animal gastroesophageal reflux disease market?
North America was the largest region in the animal gastroesophageal reflux disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal gastroesophageal reflux disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Gastroesophageal Reflux Disease (GERD) Global Market Report 2025
Gastroesophageal Reflux Disease Therapeutics Global Market Report 2025
Global Animal Therapeutics And Diagnostics Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
